Skip to content

Ardelyx ARDX EBITDA margin

EBITDA margin at other companies

Amgen logo
AmgenAMGN
41.5%+3.4pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
17%-11.8pp
AbbVie logo
AbbVieABBV
37.3%
XER
Xeris Biopharma Holdings, Inc.XERS
11.8%+8.1pp
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-0.6%-0.3pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
26.4%+4.7pp

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on trailing twelve months.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's EBITDA margin?
Ardelyx (ARDX) reported EBITDA margin of -7.9% in Q1 2026.
What is the long-term trend for Ardelyx's EBITDA margin?
Over 3 years (2020 to 2025), Ardelyx's EBITDA margin has grown at a -80.1% compound annual growth rate (CAGR), from -1,165.5% to -9.2%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.